Dobutamine in the treatment of circulatory stroke
Article describes pathogenic mechanisms of different forms of heart failure (HF), including circulatory stroke, and importance of organ microcirculatory disturbances in this disease. It gives the reasons for prescribing synthetic catecholamine dobutamine to the patients with acute HF and different types of circulatory stroke; it discusses the mechanisms of its therapeutic actions. It is underlined that dobutamine can be prescribed for the treatment of cardiogenic shock, severe HF, refractory to the treatment (especially in patients with acute myocardial infarction and after heart surgery) and severe decreasing of left ventricular function with low ejection fraction and increased filling pressure.

Keywords: cardiogenic shock, circulatory stroke, dobutamine, acute heart failure